Prelude Therapeutics
PRLD
PRLD
61 hedge funds and large institutions have $129M invested in Prelude Therapeutics in 2024 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
24% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 21
Holders
61
Holding in Top 10
–
Calls
$3K
Puts
–
Top Buyers
| 1 | +$71.8K | |
| 2 | +$67.7K | |
| 3 | +$56.2K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$55.7K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$54.2K |
Top Sellers
| 1 | -$483K | |
| 2 | -$193K | |
| 3 | -$154K | |
| 4 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
-$149K |
| 5 |
Renaissance Technologies
New York
|
-$146K |